Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Completed × Agnosia × Clear all

Phase

Phase NA 81 Phase 2 13 Phase 4 12 Phase 3 9 Phase 2/3 3 Phase 1 2 Phase EARLY_PHASE1 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 96 Prostatic Neoplasms 40 Neoplasms 40 Glioblastoma 25 Melanoma 24 Head and Neck Neoplasms 24 Brain Neoplasms 23 Ovarian Neoplasms 18 Squamous Cell Carcinoma of Head and Neck 17 Lung Neoplasms 17 Carcinoma, Renal Cell 17 Carcinoma, Hepatocellular 17 Pancreatic Neoplasms 15 Glioma 15 Carcinoma, Non-Small-Cell Lung 15 Leukemia, Myeloid, Acute 13 Colorectal Neoplasms 13 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Urinary Bladder Neoplasms 10 Lymphoma 10 Uterine Cervical Neoplasms 9 Polycystic Ovary Syndrome 9 Lymphoma, Non-Hodgkin 9 Fallopian Tube Neoplasms 9 Endometrial Neoplasms 9 Myelodysplastic Syndromes 8 Multiple Myeloma 8 Lymphoma, Mantle-Cell 8 Lymphoma, Large B-Cell, Diffuse 8 Skin Neoplasms 7

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03317730 2021-07-20

RAD 1702

University of Alabama at Birmingham

Phase EARLY_PHASE1 Completed

Agnosia, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡